Annual Operating Expenses
$16.38 M
+$1.47 M+9.84%
December 31, 2023
Summary
- As of February 7, 2025, INDP annual total operating expenses is $16.38 million, with the most recent change of +$1.47 million (+9.84%) on December 31, 2023.
- During the last 3 years, INDP annual operating expenses has risen by +$12.78 million (+355.05%).
- INDP annual operating expenses is now at all-time high.
Performance
INDP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$3.14 M
-$966.80 K-23.53%
September 1, 2024
Summary
- As of February 7, 2025, INDP quarterly total operating expenses is $3.14 million, with the most recent change of -$966.80 thousand (-23.53%) on September 1, 2024.
- Over the past year, INDP quarterly operating expenses has dropped by -$966.80 thousand (-23.53%).
- INDP quarterly operating expenses is now -29.47% below its all-time high of $4.46 million, reached on March 31, 2023.
Performance
INDP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
INDP Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.8% | -23.5% |
| 3 y3 years | +355.1% | -10.1% |
| 5 y5 years | +355.1% | -10.1% |
INDP Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +111.9% | -29.5% | at low |
| 5 y | 5-year | at high | +355.1% | -29.5% | +494.4% |
| alltime | all time | at high | +355.1% | -29.5% | +494.4% |
Indaptus Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.14 M(-23.5%) |
| Jun 2024 | - | $4.11 M(+4.2%) |
| Mar 2024 | - | $3.94 M(-5.7%) |
| Dec 2023 | $16.38 M(+9.8%) | $4.18 M(-1.6%) |
| Sep 2023 | - | $4.25 M(+21.5%) |
| Jun 2023 | - | $3.50 M(-21.5%) |
| Mar 2023 | - | $4.46 M(+9.0%) |
| Dec 2022 | $14.91 M | $4.09 M(+15.0%) |
| Sep 2022 | - | $3.55 M(-8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $3.87 M(+13.7%) |
| Mar 2022 | - | $3.40 M(+5.7%) |
| Dec 2021 | $7.73 M(+114.7%) | $3.22 M(-4.4%) |
| Sep 2021 | - | $3.37 M(+537.2%) |
| Jun 2021 | - | $528.60 K(-13.9%) |
| Mar 2021 | - | $614.00 K(-20.1%) |
| Dec 2020 | $3.60 M | - |
| Dec 2020 | - | $768.60 K(-50.3%) |
| Sep 2020 | - | $1.55 M(-46.8%) |
| Jun 2020 | - | $2.90 M |
FAQ
- What is Indaptus Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Indaptus Therapeutics?
- What is Indaptus Therapeutics annual operating expenses year-on-year change?
- What is Indaptus Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Indaptus Therapeutics?
- What is Indaptus Therapeutics quarterly operating expenses year-on-year change?
What is Indaptus Therapeutics annual total operating expenses?
The current annual operating expenses of INDP is $16.38 M
What is the all time high annual operating expenses for Indaptus Therapeutics?
Indaptus Therapeutics all-time high annual total operating expenses is $16.38 M
What is Indaptus Therapeutics annual operating expenses year-on-year change?
Over the past year, INDP annual total operating expenses has changed by +$1.47 M (+9.84%)
What is Indaptus Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of INDP is $3.14 M
What is the all time high quarterly operating expenses for Indaptus Therapeutics?
Indaptus Therapeutics all-time high quarterly total operating expenses is $4.46 M
What is Indaptus Therapeutics quarterly operating expenses year-on-year change?
Over the past year, INDP quarterly total operating expenses has changed by -$966.80 K (-23.53%)